发明名称 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
摘要 The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Abeta in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of Abeta and antibodies binding to the same.
申请公布号 US2009191231(A1) 申请公布日期 2009.07.30
申请号 US20070842116 申请日期 2007.08.20
申请人 ELAN PHARMA INTERNATIONAL LIMITED 发明人 SCHENK DALE B.;VASQUEZ NICKI;YEDNOCK THEODORE
分类号 A61K39/00;G01N33/50;A61K9/26;A61K33/06;A61K38/00;A61K38/07;A61K38/08;A61K38/17;A61K38/19;A61K38/28;A61K39/39;A61K39/395;A61K47/02;A61K47/24;A61K47/34;A61P25/28;C07H21/04;C07K14/47;C07K16/18;C07K16/40;C12N15/09;G01N33/15;G01N33/53;G01N33/567 主分类号 A61K39/00
代理机构 代理人
主权项
地址